United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

roche products ltd - cobimetinib hemifumarate - tablet - 20mg

European Union - English - EMA (European Medicines Agency)

roche registration gmbh - cobimetinib hemifumarate - melanoma - antineoplastic agents - cotellic is indicated for use in combination with vemurafenib for the treatment of adult patients with unresectable or metastatic melanoma with a braf v600 mutation.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

roche (malaysia) sdn. bhd. - cobimetinib hemifumarate -

Singapore - English - HSA (Health Sciences Authority)

roche singapore pte. ltd. - cobimetinib hemifumarate 22.20mg eqv to cobimetinib - tablet, film coated - cobimetinib hemifumarate 22.20mg eqv to cobimetinib 20mg